Molly Guthrie serves as Vice President, Policy and Advocacy, where she advances Susan G. Komen’s key legislative and regulatory objectives at the federal, state, and local levels. In this capacity, she is also responsible for leading Komen’s Center for Public Policy and ensuring its work is aligned with meeting the most pressing needs of the breast cancer community. Komen’s legislative efforts focus on policy campaigns to increase funding for medical research and screening programs and ensuring access to affordable, high-quality breast health and cancer care services. In addition to working on policy campaigns, Molly’s team recruits grassroots volunteers across the country to give a personal voice to Komen’s policy and advocacy priorities. Molly joined Susan G. Komen in 2009. Prior to joining Komen, Molly attended the University of Kansas where she received her Bachelor of General Studies with an emphasis on political science and communication studies. She worked in the Offices of Governor Kathleen Sebelius, Congressman Dennis Moore, and the Kansas Health Policy Authority during college.
Susan G. Komen commended the Massachusetts legislature for passing and Gov. Maura Healey for signing legislation that eliminates out-of-pocket expenses for diagnostic and supplemental breast imaging.
18-Nov-2024 03:55:34 PM EST
A new law in Alaska removes out-of-pocket costs for diagnostic and supplemental breast imaging for people with state-regulated insurance plans.
03-Sep-2024 02:05:06 PM EDT
Susan G. Komen applauds the Illinois General Assembly and Governor J.B. Pritzker on the passage of SB 2697, which provides expanded coverage of genetic testing for the breast cancer community.
13-Aug-2024 07:35:19 AM EDT
Susan G. Komen's statement on the passage of HB 364, which expands the prohibition of step therapy protocols for metastatic cancer patients to further include associated conditions caused by the side effects of the patient’s cancer treatment.
05-Aug-2024 06:15:00 PM EDT
Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of legislation to expand eligibility for the MO HealthNet Breast and Cervical Cancer Treatment (BCCT) program, ensuring that all eligible individuals have access to vital treatment services, regardless of where they received their cancer screening and diagnosis.
16-Jul-2024 02:50:59 PM EDT
Kansas State Employees Health Care Commission voted unanimously to eliminate the out-of-pocket costs for diagnostic and supplemental imaging for Kansas state employees with an effective date of January 1, 2024.
18-Jun-2024 07:05:26 PM EDT
Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of SB 24-086, which provides critical funding for the Women’s Wellness Connection (WWC), Colorado’s breast and cervical cancer screening program.
06-Jun-2024 03:05:41 PM EDT
Breast imaging legislation in Ohio will save thousands of lives.
05-Jun-2024 06:15:23 PM EDT
Governor Jeff Landry signed a new law passed by the Louisiana legislature that requires insurance companies to cover the cost of diagnostic and supplemental breast imaging, with no out-of-pocket costs for patients.
03-Jun-2024 10:05:06 AM EDT
Governor Chris Sununu signed a new law passed by the New Hampshire Legislature that requires insurance companies to cover the cost of diagnostic and supplemental breast imaging, with no out-of-pocket costs to patients.
03-Jun-2024 10:05:01 AM EDT
Susan G. Komen commends the Georgia General Assembly and Governor Brian Kemp for allocating $796,000 in the FY2025 budget for the state's Breast and Cervical Cancer Program.
08-May-2024 02:05:25 PM EDT
Susan G. Komen believes final recommendations made by the U.S. Preventive Services Task Force (USPSTF) on screening mammography diminish the significance of regular screening mammography and could exacerbate the troubling fact that 25% of eligible women have foregone mammograms in the past two years.
30-Apr-2024 11:05:31 AM EDT
Legislation signed by Gov. Phil Scott eliminates out-of-pocket expenses for diagnostic and supplemental imaging, which is crucial in ruling out breast cancer and a standard form of imaging for people at high-risk of breast cancer and survivors.
25-Apr-2024 03:05:02 PM EDT
Susan G. Komen commends passage of HB 115 in Kentucky, which removes out-of-pocket costs for diagnostic and supplemental imaging. This is a critical form of breast cancer screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer.
08-Apr-2024 03:05:22 PM EDT
Susan G. Komen®, commends Representative Chantelle Nickson-Clark (D-Florissant) for working with Komen to expand eligibility for the MO HealthNet Breast and Cervical Cancer Treatment (BCCT) program, providing increased access to vital breast and cervical cancer treatment services.
03-Apr-2024 01:05:31 PM EDT
Susan G. Komen is urging the U.S. House and Senate to bring the SCREENS for Cancer Act to a floor vote as soon as possible so breast health services are available to those who need them now.
20-Mar-2024 01:05:40 PM EDT
Legislation introduced in Illinois would eliminate financial barriers to clinically appropriate genetic testing and additional screenings in an effort to detect breast cancers related to a known inherited gene mutation.
25-Jan-2024 03:05:47 PM EST
Legislation introduced in South Dakota will eliminate financial barriers to earlier breast cancer detection by eliminating out-of-pocket costs for diagnostic and supplemental breast imaging.
24-Jan-2024 06:05:21 PM EST
Legislation introduced in South Dakota will eliminate financial barriers to earlier breast cancer detection by eliminating out-of-pocket costs for diagnostic and supplemental breast imaging. This imaging is critical in ruling out or confirming breast cancer but can cost hundreds-to-thousands of dollars.
24-Jan-2024 06:05:04 PM EST
Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Lisa Subeck (D-Madison) and Senator Dianne Hesslebein (D-Middleton) for introducing legislation that would prohibit the use of step therapy protocols for metastatic cancer patients.
12-Jan-2024 01:05:42 PM EST
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Ron Muzzall (R-Oak Harbor) and Representative Paul Harris (R-Vancouver) for introducing legislation that would prohibit the use of step therapy protocols for metastatic cancer patients.
12-Jan-2024 01:05:05 PM EST
Susan G. Komen commends commends the introduction of the Access to Breast Cancer Diagnosis (ABCD) Act of 2023 in the U.S. House of Representatives and the U.S. Senate. The legislation would remove a significant financial barrier to people receiving medically necessary diagnostic and supplemental breast imaging.
26-Jul-2023 01:45:49 PM EDT
Susan G. Komen® filed an amicus brief supporting the U.S. Department of Justice’s request that the Fifth Circuit Court of Appeals issue a stay in Braidwood v. Becerra.
30-Jun-2023 08:40:54 AM EDT
Lawmakers in Nevada passed and Gov. Joe Lombardo signed legislation into law that removes out-of-pocket costs for diagnostic and supplemental imaging.
07-Jun-2023 04:00:57 PM EDT
Susan G. Komen thanked Washington lawmakers for passing, and Gov. Jay Inslee, for signing diagnostic and supplemental breast imaging legislation into law.
10-May-2023 03:30:39 PM EDT
Susan G. Komen commended the Maryland General Assembly for passing diagnostic and supplemental imaging and Governor Wes Moore for signing it into law. The bill removes a financial barrier to a critical form of screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer.
03-May-2023 04:05:47 PM EDT
Susan G. Komen applauded Oklahoma lawmakers and Governor Kevin Stitt for implementing legislation to prohibit the use of step therapy requirements for metastatic cancer patients.
01-May-2023 01:00:22 PM EDT
Legislation introduced in Maine would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 1,450 people will be diagnosed with breast cancer and more than 190 will die of the disease in Maine alone.
27-Apr-2023 02:05:35 PM EDT